Incretins: all 1,182 studies that test it
Page 6 of 12. Open to participants first (46), then studies with results posted, then the rest; newest registration first within each.
- Beta-Cell Function and Sitagliptin Trial (BEST)CompletedNCT00420511Phase 2Results posted
- A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED)CompletedNCT00411554Phase 3Results posted
- Long Term Effects of DPP-IV Inhibitor Treatment in Patients With Type 2 DiabetesCompletedNCT00411411Phase 3Results posted
- Initial Combination With Pioglitazone Study (0431-064)CompletedNCT00397631Phase 3Results posted
- Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00395746Phase 3Results posted
- Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes MellitusCompletedNCT00395512Phase 3Results posted
- Sitagliptin Added-on to Insulin Study (0431-051)CompletedNCT00395343Phase 3Results posted
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00393718Phase 3Results posted
- Effect on Weight Loss of Exenatide Versus PlaceboCompletedNCT00375492Phase 3Results posted
- A Study Assessing Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseCompletedNCT00374907Phase 3Results posted
- MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED)CompletedNCT00372060Phase 3Results posted
- Incretins in Impaired Fasting GlucoseCompletedNCT00364377Phase 4Results posted
- A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes PatientsCompletedNCT00360334Phase 3Results posted
- Exenatide Versus Glimepiride in Patients With Type 2 DiabetesCompletedNCT00359762Phase 3Results posted
- The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 DiabetesCompletedNCT00353834Phase 4Results posted
- Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)CompletedNCT00350779Phase 3Results posted
- Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes MellitusCompletedNCT00337610Phase 3Results posted
- Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.CompletedNCT00328627Phase 3Results posted
- Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes PatientsCompletedNCT00328172Phase 2Results posted
- A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseCompletedNCT00327015Phase 3Results posted
- To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given TogetherCompletedNCT00318461Phase 3Results posted
- Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseCompletedNCT00316082Phase 3Results posted
- A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With SulfonylureasCompletedNCT00313313Phase 3Results posted
- Efficacy and Safety of BI 1356 BS (Linagliptin) in Combination With Metformin in Patients With type2 DiabetesCompletedNCT00309608Phase 2Results posted
- Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)CompletedNCT00308139Phase 3Results posted
- Long-term Safety of Alogliptin in Patients With Type 2 Diabetes MellitusCompletedNCT00306384Phase 3Results posted
- Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED)CompletedNCT00305604Phase 3Results posted
- A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy AloneCompletedNCT00295633Phase 3Results posted
- To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1cTerminatedNCT00294723Phase 3Results posted
- MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040)CompletedNCT00289848Phase 3Results posted
- Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes MellitusCompletedNCT00286494Phase 3Results posted
- Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.CompletedNCT00286468Phase 3Results posted
- Efficacy and Safety of Alogliptin in Subjects With Type 2 DiabetesCompletedNCT00286455Phase 3Results posted
- Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes MellitusCompletedNCT00286442Phase 3Results posted
- Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes.CompletedNCT00286429Phase 3Results posted
- An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes MellitusCompletedNCT00135330Phase 3Results posted
- A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044)CompletedNCT00127192Phase 2Results posted
- Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin AloneCompletedNCT00121667Phase 3Results posted
- Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseCompletedNCT00121641Phase 3Results posted
- Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)CompletedNCT00106704Phase 3Results posted
- MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036)CompletedNCT00103857Phase 3Results posted
- Effects of Exenatide and Insulin Glargine in Subjects With Type 2 DiabetesCompletedNCT00097500Phase 3Results posted
- An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED)CompletedNCT00095056Phase 3Results posted
- An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024)CompletedNCT00094770Phase 3Results posted
- An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023)CompletedNCT00094757Phase 3Results posted
- Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)CompletedNCT00087516Phase 3Results posted
- Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)CompletedNCT00086515Phase 3Results posted
- Pioglitazone Add-on Study in Patients With Type 2 Diabetes MellitusCompletedNCT00086502Phase 3Results posted
- Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and MetforminCompletedNCT00082407Phase 3Results posted
- Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and MetforminCompletedNCT00082381Phase 3Results posted
- Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCl25 mg/5 mg/1000 mg Extended Release Tablet Versus Trijardy® XR 25 mg/5 mg/1000 mg Extended- Release TabletsCompletedNCT07872358Phase 1
- Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 100 mg/1000 mg in Healthy Subjects, Fed Study.CompletedNCT07763964Not applicable
- Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 100 mg/1000 mg in Healthy Subjects, Fast Study.CompletedNCT07763951Not applicable
- Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fed Study.CompletedNCT07763912Not applicable
- Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fast Study.CompletedNCT07763899Not applicable
- Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCl 25 mg/5 mg/1000 mg Extended Release Tablet Versus Trijardy® XR 25 mg/5 mg/1000 mg Extended- Release TabletsCompletedNCT07691203Phase 1
- Bioequivalence Study of Sitagliptin/Metformin Extended-Release Tablets in Healthy SubjectsCompletedNCT07679711Phase 1
- Use of Liraglutide in Children Aged 6 to 12 Years With Severe ObesityActive, not recruitingNCT07590219Phase 4
- A Phase 1 Study to Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin Drug Levels in Healthy Adults.CompletedNCT07567781Phase 1
- Dose Optimization of Sitagliptin and Duloxetine in Diabetic CirrhosisCompletedNCT07439536Phase 4
- Research on Timing of Liraglutide Therapy in Patients With Obesity After Metabolic SurgeryCompletedNCT07374445Phase 4
- GLP-1 Medicines and Mental Health ChangesCompletedNCT07368855Not applicable
- A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and OsteoarthritisCompletedNCT07225829Phase 2
- Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCL 25mg/5mg/1000mg Extended-Release Tablets Versus Trijardy® XR Extended Release Film Coated TabletsCompletedNCT07213895Phase 1
- The Effect of Sitagliptin, Pioglitazone and Dapagliflozine on Myocardial Infarction in Diabetic RatsCompletedNCT07083232Phase 4
- Effect of Sitagliptin and Empagliflozin in Combination With Metformin on Hs-CRP Levels in Patients With Type 2 Diabetes MellitusCompletedNCT06952231Phase 3
- Bioequivalence Study to Compare Empagliflozin + Linagliptin 25 mg/5 mg Film-coated Tablets Versus Glyxambi 25 mg/ 5 mg Film-coated TabletsCompletedNCT06932159Phase 1
- The Separate and Combined Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Subjects With and Without Type 1 DiabetesCompletedNCT06881472Not applicable
- Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.CompletedNCT06851962Phase 4
- Investigation of the Relationship Between Peripheral and Central Metabolic Changes Induced by GLP-1 AgonistsCompletedNCT06818292Not applicable
- DPP4-Inhibitors and Bone Metabolism in DiabetesCompletedNCT06770894Phase 3
- Comparative Study of Sitagliptin and Gliclazide With Metformin in Type 2 Diabetes Patients With GlucotoxicityCompletedNCT06613750Phase 4
- Exenatide For Reducing the Reinforcing Effects of CocaineWithdrawnNCT06252623Phase 1
- Liraglutide Effectiveness in Preoperative Weight-loss for Bariatric-metabolic SurgeryCompletedNCT06201819Phase 4
- Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory IssuesSuspendedNCT06171152Early Phase 1
- Effect of Sitagliptin on Polycystic Ovarian Syndrome PatientsCompletedNCT05972928Phase 2/3
- Effect of Liraglutide in Obese Women With Polycystic Ovary SyndromeCompletedNCT05965908Phase 3
- High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHDWithdrawnNCT05895201Phase 1/2
- A Pharmacokinetic Study of DW6013 (FDC of Linagliptin and Metformin) in Healthy Adult Volunteers in Fed ConditionCompletedNCT05874180Phase 1
- A Pharmacokinetic Study of DW6013 (FDC of Linagliptin and Metformin) in Healthy Adult VolunteersCompletedNCT05874167Phase 1
- Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 AnalogueStatus unknownNCT05767255Phase 3
- Assessment of Safety, Tolerability and Drug Levels of Exenatide ImplantCompletedNCT05670379Phase 1
- Exenatide for Smoking Cessation and Prevention of Weight GainCompletedNCT05610800Phase 2
- SITAgliptin Plus GLARgine to Glycemic Control in the Hospital Setting (SITAGLAR-H)CompletedNCT05579119Phase 4
- Non-alcoholic Fatty Liver Disease and Its TreatmentCompletedNCT05480007Not applicable
- Effect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes MellitusCompletedNCT05467514Phase 3
- A Pharmacokinetic Study of DW6012 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult VolunteersCompletedNCT05403281Phase 1
- Obesity Treatment to Improve DiabetesCompletedNCT05390307Not applicable
- Effects of Degludec/Liraglutide on Time in Range, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic InpatientsCompletedNCT05360537Phase 4
- Liraglutide Improve Cognitive Function in Patients With Type 2 Diabetes MellitusCompletedNCT05360147Phase 3
- Which is Better to Start With DPP-4 Inhibitors or SGLT-2 Inhibitors in Egyptian Diabetic Patients?CompletedNCT05359341Not applicable
- The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05353673Phase 2
- LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 DiabetesCompletedNCT05313529Not applicable
- Effect of Liraglutide on Weight Loss in Patients Who Have Undergone Revisional Bariatric Surgeries.Status unknownNCT05285397Not applicable
- Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight LossStatus unknownNCT05268627Not applicable
- Phase 1 Bioequivalence Study of Dapagliflozin/Sitagliptin FDC vs Loose Combination of Single ComponentsCompletedNCT05266404Phase 1
- A Randomized Phase 1 Study of Liralutide Injection in Healthy Chinese SubjectsCompletedNCT05225974Phase 1
- Efficacy of Empagliflozin or Linagliptin as an Alternative to Metformin for Treatment of Polycystic Ovary SyndromeStatus unknownNCT05200793Phase 4
- Monitoring Parameters Beyond Glycemic Control: Impact of Sitagliptin on Quality of Life in Type 2 Diabetes PatientsCompletedNCT05167513Phase 4
- The Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients with Type 2 DiabetesCompletedNCT05078255Not applicable